Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

11,095 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Outcomes with allogeneic stem cell transplant using cryopreserved versus fresh hematopoietic progenitor cell products.
Wan BA, Lindo L, Mourad YA, Chung S, Forrest D, Kuchenbauer F, Nantel S, Narayanan S, Nevill T, Power M, Rodrigo J, Sanford D, Song K, Stubbins RJ, Sutherland H, Toze CL, White J, Roy C, Hay KA. Wan BA, et al. Among authors: white j. Cytotherapy. 2024 Oct;26(10):1210-1216. doi: 10.1016/j.jcyt.2024.05.009. Epub 2024 May 8. Cytotherapy. 2024. PMID: 38819367 Free article.
Outcomes of Intermediate Risk Karyotype Acute Myeloid Leukemia in First Remission Undergoing Autologous Stem Cell Transplantation Compared With Allogeneic Stem Cell Transplantation and Chemotherapy Consolidation: A Retrospective, Propensity-score Adjusted Analysis.
Limvorapitak W, Barnett MJ, Hogge DE, Forrest DL, Nevill TJ, Narayanan S, Power MM, Nantel SH, Broady R, Song KW, Toze CL, Mourad YA, Sutherland HJ, Gerrie AS, White J, Sanford DS. Limvorapitak W, et al. Among authors: white j. Clin Lymphoma Myeloma Leuk. 2018 Nov;18(11):e481-e491. doi: 10.1016/j.clml.2018.07.290. Epub 2018 Jul 17. Clin Lymphoma Myeloma Leuk. 2018. PMID: 30100330 Clinical Trial.
Outpatient Autologous Stem Cell Transplants for Multiple Myeloma: Analysis of Safety and Outcomes in a Tertiary Care Center.
Kodad SG, Sutherland H, Limvorapitak W, Abou Mourad Y, Barnett MJ, Forrest D, Gerrie A, Hogge DE, Nantel SH, Narayanan S, Nevill T, Power M, Sanford D, Toze C, White J, Broady R, Song K. Kodad SG, et al. Among authors: white j. Clin Lymphoma Myeloma Leuk. 2019 Dec;19(12):784-790. doi: 10.1016/j.clml.2019.09.619. Epub 2019 Oct 9. Clin Lymphoma Myeloma Leuk. 2019. PMID: 31678079
Mortality from Multiple Myeloma Within One Year Following Autologous Stem Cell Transplantation: Defining an Ultra-high Risk Population.
Cherniawsky HM, AlAhwal H, Mourad YA, Forrest D, Gerrie A, Kuchenbauer F, Nantel SH, Narayanan S, Nevill T, Power M, Sanford D, Toze C, White J, Escano L, Sutherland H, Song K. Cherniawsky HM, et al. Among authors: white j. Clin Lymphoma Myeloma Leuk. 2021 Jul;21(7):476-482. doi: 10.1016/j.clml.2021.02.012. Epub 2021 Mar 4. Clin Lymphoma Myeloma Leuk. 2021. PMID: 33814336
Incidence and socioeconomic factors in older adults with acute myeloid leukaemia: Real-world outcomes from a population-based cohort.
Stubbins RJ, Stamenkovic M, Roy C, Rodrigo J, Chung S, Kuchenbauer FC, Hay KA, White J, Abou Mourad Y, Power MM, Narayanan S, Forrest DL, Toze CL, Sutherland HJ, Nantel SH, Nevill TJ, Karsan A, Song KW, Sanford DS. Stubbins RJ, et al. Among authors: white j. Eur J Haematol. 2022 May;108(5):437-445. doi: 10.1111/ejh.13752. Epub 2022 Feb 14. Eur J Haematol. 2022. PMID: 35122325
Real-World Impact of Routine Addition of Antithymocyte Globulin to Standard GVHD Prophylaxis in Myeloablative Unrelated Donor Transplants: Important Gains in Graft-versus-Host Disease Prevention though No Difference in Overall Survival.
Bai N, Limvorapitak W, Henderson R, Abou Mourad Y, Chung S, Forrest D, Hay K, Kuchenbauer F, Nantel S, Narayanan S, Nevill T, Power M, Rodrigo J, Roy C, Sanford D, Song K, Stubbins R, Sutherland H, Toze C, White J. Bai N, et al. Among authors: white j. Acta Haematol. 2024 Aug 28:1-11. doi: 10.1159/000541071. Online ahead of print. Acta Haematol. 2024. PMID: 39197435
Patient-reported treatment response in chronic graft-versus-host disease.
Im A, Pusic I, Onstad L, Kitko CL, Hamilton BK, Alousi AM, Flowers ME, Sarantopoulos S, Carpenter P, White J, Arai S, El Jurdi N, Chen G, Cutler C, Lee S, Pidala J. Im A, et al. Among authors: white j. Haematologica. 2024 Jan 1;109(1):143-150. doi: 10.3324/haematol.2023.282734. Haematologica. 2024. PMID: 37226713 Free PMC article.
Cell Therapy Transplant Canada (CTTC) Consensus-Based Guideline 2024 for Management and Treatment of Chronic Graft-Versus-Host Disease and Future Directions for Development.
Kim DDH, Popradi G, Lepic K, Paulson K, Allan D, Nampoothiri RV, Lachance S, Deotare U, White J, Elemary M, Jamani K, Fraga C, Lemieux C, Novitzky-Basso I, Law AD, Kumar R, Walker I, Schultz KR; CTTC Chronic GVHD Guideline Working Group. Kim DDH, et al. Among authors: white j. Curr Oncol. 2024 Mar 8;31(3):1426-1444. doi: 10.3390/curroncol31030108. Curr Oncol. 2024. PMID: 38534941 Free PMC article.
11,095 results
You have reached the last available page of results. Please see the User Guide for more information.